Form 4: XPO Director Exercises RSUs, Acquires Shares
Insider Transaction Report
XPO Director Bella Loykhter Allaire exercised 1,374 Restricted Stock Units and acquired 1,374 shares of common stock, while also receiving a new grant of 1,357 RSUs.
Summary
- Bella Loykhter Allaire, a Director of XPO, Inc., exercised 1,374 Restricted Stock Units (RSUs) on January 2, 2026.
- Upon exercise, 1,374 shares of XPO Common Stock were acquired at a price of $138.79 per share.
- Following this transaction, the reporting person beneficially owns 9,916 shares of Common Stock directly.
- A new grant of 1,357 Restricted Stock Units was also received on January 2, 2026, which will vest in full on January 4, 2027, subject to continued service as a director.
- The transactions were made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 7
Explanation: The filing reports a routine insider transaction involving the exercise of vested RSUs and a new RSU grant. This is generally a neutral to slightly positive event, indicating continued director engagement and compensation, but does not provide new fundamental information to significantly alter market sentiment.
Positives
- The director increased their direct beneficial ownership of XPO Common Stock by 1,374 shares, demonstrating continued alignment with shareholder interests.
- The grant of 1,357 new Restricted Stock Units indicates ongoing compensation and retention of the director.
Risks
- The vesting of the newly granted 1,357 Restricted Stock Units is contingent upon the reporting person's continued service as a director of XPO, Inc.
Future Outlook
The newly granted 1,357 Restricted Stock Units are scheduled to vest in full on January 4, 2027, contingent on the director's continued service.
Industry Context
This filing represents a routine insider transaction for a director, common across publicly traded companies as part of their executive and board compensation structures, often involving equity-based incentives like Restricted Stock Units.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adherence | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 01/02/2026 | Indicates adherence to insider trading compliance policies, providing a pre-arranged plan for equity transactions. |
Stakeholder Impact
- Shareholders: The increase in direct beneficial ownership by a director aligns their interests more closely with those of other shareholders, potentially signaling confidence in the company's future.
Next Steps
- Vesting of 1,357 Restricted Stock Units on January 4, 2027, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of earliest transaction, including RSU exercise, common stock acquisition, and new RSU grant. |
| 01/05/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
| 01/04/2027 | Date when the newly granted 1,357 Restricted Stock Units are scheduled to vest in full. |
Recommendation
holdThis Form 4 reports a routine insider transaction where a director exercised vested Restricted Stock Units and received a new grant. While it shows continued director engagement and ownership, it does not provide new fundamental information to warrant a change in investment recommendation. The transaction is a standard part of executive compensation and does not reflect a change in the company's operational or financial outlook.
Keywords
XPO, Insider Transaction, Form 4, Restricted Stock Units, Director Compensation, Equity Grant, Common Stock, Bella Loykhter Allaire, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.